$ADVM - Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020: https://finance.yahoo.com/news/adverum-biotechnologies-reports-interim-data-200634533.html
$TCO - TAUBMAN CENTERS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout: https://finance.yahoo.com/news/taubman-centers-inc-shareholder-alert-171500462.html
$VTVT - vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes: https://finance.yahoo.com/news/vtv-therapeutics-announces-positive-results-120010210.html